Theresa Matkovits

Theresa Matkovits

Director/Board Member at APPILI THERAPEUTICS INC.

Net worth: - $ as of 30/07/2026

58 year
Health Technology
Consumer Services
Distribution Services

Profile

Theresa Matkovits is currently Chairman at GoodCap Pharmaceuticals, Inc. since 2022 and Lead Independent Director at Appili Therapeutics, Inc. since 2018.
Former roles include Director at Aradigm Corp.
from 2018 to 2019, Director at BioSurplus, Inc., Chief Operating Officer at Hepion Pharmaceuticals, Inc. from 2017 to 2018, Head-Strategic Planning & Operations at Novartis AG from 1997 to 2010, Vice President at The Medicines Co. from 2010 to 2013, and Chief Development Officer at Matinas BioPharma Holdings, Inc. from 2018 to 2024.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey conferred in 1994 and an undergraduate degree from Alfred University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/06/2026 0 ( -.--% ) - $ 30/07/2026

Theresa Matkovits active positions

CompaniesPositionStart
APPILI THERAPEUTICS INC. Director/Board Member 30/09/2018
Chairman 31/12/2021

Former positions of Theresa Matkovits

CompaniesPositionEnd
MATINAS BIOPHARMA HOLDINGS, INC. Corporate Officer/Principal 22/10/2024
ARADIGM CORPORATION Director/Board Member 31/01/2019
HEPION PHARMACEUTICALS, INC. Chief Operating Officer 30/09/2018
THE MEDICINES COMPANY Corporate Officer/Principal 30/04/2013
NOVARTIS AG Corporate Officer/Principal 31/12/2009
See the detail of Theresa Matkovits's experience

Training of Theresa Matkovits

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Distribution Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Theresa Matkovits
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!